Central Pharmaceuticals Limited IPO

বৃহস্পতিবার, ২৩ মে, ২০১৩

Central Pharmaceuticals Limited (As per abridged version of Prospectus)
Nature of Business	The principal activities of the Company throughout the year continued to be manufacturing and marketing of quality medicine.
Major Product	The Company is producing and marketing finished formulation products for general Peoples, Hospitals, Clinic, Govt. Organizations, NGO’s, Corporations & other Non-govt. Organizations.
Subscription Open	May 26, 2013
Subscription Close	May 30, 2013
Subscription period for NRB	May 26, 2013 to June 08, 2013
Authorized Capital	Tk. 1,000,000,000
Pre- IPO paid-up Capital	Tk. 480,000,000
IPO size in shares	14,000,000
IPO size in Tk. at face value	Tk. 140,000,000
IPO size in Tk. at offer price	Tk. 140,000,000
Post IPO Paid-up Capital	Tk. 620,000,000
Face Value per share	Tk. 10.00
Offer Price per share	Tk. 10.00
Market Lot (Shares)	500
Use of IPO Proceeds	The Company will raise paid-up capital through Initial Public Offering (IPO) in order to repayment of its debt to enhance profitability.
NAV per share	Tk. 11.28 as on June 30, 2012.
EPS	Tk. 1.21 for the year ended on June 30, 2012.
Issue Manager	Janata Capital and Investment Limited
Auditors	KAZI ZAHIR KHAN & CO.
Website	www.centralphl.com

Tags: IPO, Upcoming IPO

IPO Results